Gene: CD19

930
B4|CVID3
CD19 molecule
protein-coding
16p11.2
Ensembl:ENSG00000177455 MIM:107265 Vega:OTTHUMG00000097049 UniprotKB:P15391
NG_007275.1
PubMed
CD|ND|AD
48   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.078e-1 (AD)  8.953e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
GADL10.798
DPPA40.744
IL2RB0.728
FCRL30.727
C16orf540.727
SLAMF60.727
ASB90.723
FMO10.714
TRIM60.713
MROH50.712

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
FUT9-0.427
LGI1-0.417
B3GALT1-0.416
GREB1-0.413
SLC1A4-0.409
CYP46A1-0.408
BDH1-0.397
ADCY2-0.394
ZNF835-0.383
KIAA0319-0.383

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB06342Coltuximab ravtansineBiotechDrug1269764-99-9InvestigationalTarget
DB09052BlinatumomabBiotechDrug853426-35-4Approved|InvestigationalTarget
DB13881TisagenlecleucelBiotechDrug1823078-37-0Approved|InvestigationalTarget
DB13915Axicabtagene ciloleucelBiotechDrugApprovedTarget
ID Drug Name Action PubMed
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD19 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD19 mRNA"27188386
C030935benz(a)anthracenebenz(a)anthracene results in increased expression of CD19 mRNA26377693
C006703benzo(b)fluoranthenebenzo(b)fluoranthene results in increased expression of CD19 mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of CD19 mRNA21569818
C023888beta-hexachlorocyclohexanebeta-hexachlorocyclohexane results in increased expression of CD19 mRNA25270620
C006780bisphenol Abisphenol A affects the expression of CD19 mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of CD19 gene28505145
D002084Butylated HydroxytolueneButylated Hydroxytoluene results in decreased expression of CD19 mRNA19925653
D002392Catechin[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of CD19 mRNA24763279
D002392CatechinCatechin results in increased expression of CD19 mRNA15465739
D002737ChloropreneChloroprene results in decreased expression of CD19 mRNA23125180
D016264Dextran SulfateDextran Sulfate results in increased expression of CD19 mRNA23894361
D004041Dietary FatsDietary Fats results in increased expression of CD19 mRNA25016146
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in decreased expression of CD19 mRNA28412506
D0198131,2-Dimethylhydrazine"[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of CD19 mRNA"27840820
C118739entinostatentinostat results in increased expression of CD19 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CD19 mRNA"27188386
C442659ethinyl estradiol-desogestrel combinationethinyl estradiol-desogestrel combination results in increased expression of CD19 protein10813102
C069837fullerene C60fullerene C60 results in increased expression of CD19 mRNA19167457
C511402Grape Seed Proanthocyanidins[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of CD19 mRNA24763279
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CD19 mRNA25613284
D015122MercaptopurineMercaptopurine results in decreased expression of CD19 mRNA23358152
D008727MethotrexateMethotrexate results in decreased expression of CD19 mRNA17400583
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of CD19 mRNA23649840
D037742Nanotubes, Carbon"Nanotubes, Carbon affects the expression of CD19 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of CD19 mRNA"25554681
C017096n-butoxyethanoln-butoxyethanol results in decreased expression of CD19 mRNA19812364
C028007nickel monoxidenickel monoxide results in increased expression of CD19 mRNA19167457
D010126OzoneTTPA protein affects the reaction [Ozone results in decreased expression of CD19 mRNA]19555225
D010126OzoneOzone results in decreased expression of CD19 mRNA28623178
D052638Particulate MatterParticulate Matter results in decreased expression of CD19 mRNA23638009
C006253pirinixic acidpirinixic acid results in decreased expression of CD19 mRNA17426115
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in decreased expression of CD19 mRNA28903501
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of CD19 mRNA25895662
D053260SootSoot results in decreased expression of CD19 mRNA26551751
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CD19 mRNA21570461
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CD19 mRNA25613284
C009495titanium dioxidetitanium dioxide results in increased expression of CD19 mRNA23557971
D014028Tobacco Smoke PollutionTobacco Smoke Pollution affects the expression of CD19 mRNA20133372
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of CD19 mRNA"26179874
D014520UrethaneUrethane results in decreased expression of CD19 mRNA28818685
D014635Valproic AcidValproic Acid affects the expression of CD19 mRNA25979313
D014635Valproic AcidValproic Acid results in increased methylation of CD19 gene29154799

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005515protein binding-IPI19214191  24963139  
GO:0046934phosphatidylinositol-4,5-bisphosphate 3-kinase activity-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006968cellular defense response-TAS1373518  
GO:0007166cell surface receptor signaling pathway-TAS1714482  
GO:0030449regulation of complement activation-TAS-  
GO:0046854phosphatidylinositol phosphorylation-IEA-  
GO:0050776regulation of immune response-TAS-  
GO:0050853B cell receptor signaling pathway-IBA21873635  
GO:0051281positive regulation of release of sequestered calcium ion into cytosol-IEA-  
GO:0051897positive regulation of protein kinase B signaling-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-TAS2472450  
GO:0009897external side of plasma membrane-IBA21873635  
GO:0009897external side of plasma membrane-IDA17213291  20660734  
GO:0032991protein-containing complex-IDA23071339  
GO:0070062extracellular exosome-HDA20458337  
KEGG ID KEGG Term
hsa04640Hematopoietic cell lineage
hsa04662B cell receptor signaling pathway
hsa05340Primary immunodeficiency
Reactome ID Reactome Term Evidence
R-HSA-1257604PIP3 activates AKT signalingTAS
R-HSA-1280218Adaptive Immune SystemTAS
R-HSA-162582Signal TransductionTAS
R-HSA-1643685DiseaseTAS
R-HSA-166658Complement cascadeTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-198933Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellTAS
R-HSA-199418Negative regulation of the PI3K/AKT networkTAS
R-HSA-2219528PI3K/AKT Signaling in CancerTAS
R-HSA-2219530Constitutive Signaling by Aberrant PI3K in CancerTAS
R-HSA-5663202Diseases of signal transductionTAS
R-HSA-6811558PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingTAS
R-HSA-9006925Intracellular signaling by second messengersTAS
R-HSA-977606Regulation of Complement cascadeTAS
R-HSA-983695Antigen activates B Cell Receptor (BCR) leading to generation of second messengersTAS
R-HSA-983705Signaling by the B Cell Receptor (BCR)TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
10366792An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. (1999 Jun)Santagostino AHaematologica
20605406Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan. (2010 Aug)Lee JJInt J Oral Maxillofac Surg
20512441Is self-rated health associated with blood immune markers in healthy individuals? (2010 Sep)Nakata AInt J Behav Med
26412231Differences in oral habit and lymphocyte subpopulation affect malignant transformation of patients with oral precancer. (2016 Apr)Yeh CYJ Formos Med Assoc
8564094Elevated B cells in sputum of asthmatics. Close correlation with eosinophils. (1996 Feb)Kidney JCAm J Respir Crit Care Med
8940654Lymphocyte subpopulations of workers in a plant producing plastic materials (preliminary study). (1995 Jan-Nov)Boscolo PG Ital Med Lav
8986204Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. (1996 Dec)Laso FJAlcohol Clin Exp Res
11852118Lymphocyte phenotype analysis and chromosome aberration frequency of workers occupationally exposed to styrene, benzene, polycyclic aromatic hydrocarbons or mixed solvents. (2002 Apr 22)Biro AImmunol Lett
23646229Lymphocyte subsets in alcoholic liver disease. (2013 Feb 27)Matos LCWorld J Hepatol
9377748[Trace elements in biological samples and immunologic parameters in environmentally exposed populations (preliminary study)]. (1997 Jan-Mar)Boscolo PG Ital Med Lav Ergon
19347744Patients referred to an indoor air health clinic: exposure to water-damaged buildings causes an increase of lymphocytes in bronchoalveolar lavage and a decrease of CD19 leucocytes in peripheral blood. (2009)Wolff HScand J Clin Lab Invest
24952144Assessment of selected B cells populations in the workers of X-ray departments. (2014 Jun)Klucinski PInt J Occup Med Environ Health
21291536The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. (2011 Feb 3)Borges-Almeida EBMC Infect Dis
15152820Lymphocyte numbers and function in relation to periodontitis and smoking. (2004 Apr)Loos BGJ Periodontol
20044880Immunotoxicity and hematotoxicity induced by tetrachloroethylene in egyptian dry cleaning workers. (2010 Feb)Emara AMInhal Toxicol
22013978Dynamics of lymphocyte subsets in children living in an area polluted by polychlorinated biphenyls. (2011 Oct-Dec)Horvathova MJ Immunotoxicol
8586328[Characterization of bronchoalveolar space cells in pulmonary sarcoidosis]. (1994)Czarnobilska EFolia Med Cracov
15031634Relationships of differential leukocyte and lymphocyte subpopulations with carotid atherosclerosis in elderly men. (2003 Nov)Tanigawa TJ Clin Immunol
22955940Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors. (2012 Nov)Sagan AThromb Haemost
17291406The immune response of women with prolonged exposure to electromagnetic fields produced by radiotelevision broadcasting stations. (2006 Oct-Dec)Boscolo PInt J Immunopathol Pharmacol
8883436Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. (1996 Oct)Manganelli PBr J Rheumatol
21113743Immunotoxicity monitoring of hospital staff occupationally exposed to cytostatic drugs. (2011 Jun)Biro APathol Oncol Res
22538526Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study. (2012)Garcia-Dabrio MCActa Haematol
22326931Perspectives on the causes of childhood leukemia. (2012 Apr 5)Wiemels JChem Biol Interact
23994583Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma. (2013 Dec)Andrade MCHum Immunol
9122514Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. (1997 Feb)de Jong JWRespir Med
17893969Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients. (2007 Jun)Sailler LAnn N Y Acad Sci
10865416The effects of cigarette smoking on peripheral blood leukocytes and lymphocyte subpopulations: an urban population-based study in Thailand. (2000 Mar)Apibal SJ Med Assoc Thai
26167746Lymphocyte Subsets in a Population of Nonfrail Elderly Individuals. (2015)Valdiglesias VJ Toxicol Environ Health A
10069570Upregulated expression of VLA proteins and CD29 in peripheral blood lymphocytes of chronic alcoholics without ethanol-related diseases. (1999 Feb)Sacanella EAlcohol Clin Exp Res
18220159Occupational benzene exposure from vehicular sources in India and its effect on hematology, lymphocyte subsets and platelet P-selectin expression. (2007 Apr)Ray MRToxicol Ind Health
8979026Long lasting immunological effects of ethanol after withdrawal. (1996 Dec 15)Laso FJCytometry
9330248Lymphocyte subsets in peripheral blood and smoking habits. (1997)Schaberg TLung
10091947Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. (1999)Hoser GFolia Histochem Cytobiol
23046204Immunotoxicity and pulmonary toxicity induced by paints in Egyptian painters. (2013 Jul-Sep)El-Gharabawy RMJ Immunotoxicol
10560533Lymphocyte subsets and sister-chromatid exchanges in the students exposed to formaldehyde vapor. (1999 Jun)Ying CJBiomed Environ Sci
7709007Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values. (1995 Feb)Sutinen SRespir Med
2786361The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. (1989 Jun)Tollerud DJAm Rev Respir Dis
9886155Increase in memory (CD4+CD29+ and CD4+CD45RO+) T and naive (CD4+CD45RA+) T-cell subpopulations in smokers. (1998 Nov-Dec)Tanigawa TArch Environ Health
17085920Decreases in CD8+ T, naive (CD4+CD45RA+) T, and B (CD19+) lymphocytes by exposure to manganese fume. (2006 Oct)Nakata AInd Health
9816580[The effects of occupational exposure to nitrogen dioxide (NO2) on the immunological parameters in workers]. (1998)Rutowski JMed Pr
9045748Changes in immunologic cell surface markers during cocaine withdrawal in pregnant women. (1996 Dec)Johnson TRBrain Behav Immun
1683282Immunologic biomarkers associated with an acute exposure to exothermic byproducts of a ureaformaldehyde spill. (1991 Aug)Madison REEnviron Health Perspect
2067132Differential depression of lymphocyte subsets according to stage in stomach cancer. (1991 Apr)Hong WSJpn J Clin Oncol
11055179[Evaluation of selected immunological parameters in alcohol dependence syndrome]. (2000 May-Jun)Krol WPsychiatr Pol
9660319Activated lymphocytes (CD25+ CD69+ cells) and decreased CD19+ cells in well-nourished chronic alcoholics without ethanol-related diseases. (1998 Jun)Sacanella EAlcohol Clin Exp Res
29287311Hypomethylation of CYP2E1 and DUSP22 Promoters Associated With Disease Activity and Erosive Disease Among Rheumatoid Arthritis Patients. (2018 Apr)Mok AArthritis Rheumatol
22901197Elevated circulating CD19+ lymphocytes predict survival advantage in patients with gastric cancer. (2012)Yu QMAsian Pac J Cancer Prev